Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −6 vs. Q1 2021
- Shares held
- 2.32M
- −831.7K (−26.4%) vs. Q1 2021
- Total value
- $22.7M
- −$23.1M (−50.5%) vs. Q1 2021
- New holders
- 3
- 14 more added
- Sold out
- 9
- 13 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 300 | $3.00K | 0.00% | +300 | New |
| Citigroup Inc | 362 | $4.00K | 0.00% | −145−28.6% | Reduced |
| Legal & General Group Plc | 593 | $6.00K | 0.00% | −124−17.3% | Reduced |
| Ameritas Investment Partners, Inc. | 620 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 694 | $7.00K | 0.00% | −1,405−66.9% | Reduced |
| Royal Bank of Canada | 679 | $7.00K | 0.00% | −56−7.6% | Reduced |
| Tower Research Capital LLC (TRC) | 1,410 | $14.0K | 0.00% | +840+147.4% | Added |
| American International Group, Inc. | 4,266 | $42.0K | 0.00% | −175−3.9% | Reduced |
| Deutsche Bank AG | 4,653 | $45.0K | 0.00% | −12,779−73.3% | Reduced |
| New York State Common Retirement Fund | 5,396 | $53.0K | 0.00% | +1,462+37.2% | Added |
| California State Teachers Retirement System | 10,529 | $103.0K | 0.00% | −965−8.4% | Reduced |
| Wells Fargo & Company | 11,081 | $108.0K | 0.00% | +8,701+365.6% | Added |
| Bank of America Corp | 11,675 | $115.0K | 0.00% | −2,288−16.4% | Reduced |
| Nuveen Asset Management, LLC | 12,536 | $122.0K | 0.00% | +196+1.6% | Added |
| Bank of New York Mellon Corp | 18,431 | $180.0K | 0.00% | +4,369+31.1% | Added |
| Two Sigma Investments, LP | 18,551 | $181.0K | 0.00% | −27,561−59.8% | Reduced |
| Pura Vida Investments, LLC | 22,603 | $208.0K | 0.01% | −44,754−66.4% | Reduced |
| Two Sigma Advisers, LP | 23,200 | $226.0K | 0.00% | +12,200+110.9% | Added |
| Tudor Investment Corp Et Al | 28,111 | $274.0K | 0.01% | −85,242−75.2% | Reduced |
| Alyeska Investment Group, L.P. | 40,000 | $390.0K | 0.00% | +40,000 | New |
| Alps Advisors Inc | 40,286 | $393.0K | 0.00% | +40,286 | New |
| Zimmer Partners, LP | 46,000 | $449.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 54,965 | $537.0K | 0.00% | +8,720+18.9% | Added |
| Northern Trust Corp | 75,011 | $733.0K | 0.00% | −6,936−8.5% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $976.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 100,000 | $976.0K | 0.00% | +41,229+70.2% | Added |
| Formula Growth Ltd | 100,000 | $976.0K | 0.13% | +43,724+77.7% | Added |
| Morgan Stanley | 107,726 | $1.05M | 0.00% | +101,151+1,538.4% | Added |
| Moore Capital Management, LP | 127,500 | $1.24M | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 141,809 | $1.38M | 0.00% | +24,403+20.8% | Added |
| JPMorgan Chase & Co | 179,078 | $1.75M | 0.00% | +23,431+15.1% | Added |
| Citadel Advisors LLC | 283,667 | $2.77M | 0.00% | −408,870−59.0% | Reduced |
| BlackRock Inc. | 363,466 | $3.55M | 0.00% | +30,766+9.2% | Added |
| Vanguard Group Inc | 387,753 | $3.78M | 0.00% | +63,057+19.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −213,658−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −27,603−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Serengeti Asset Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −18,273−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,629−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −270−100.0% | Sold out |